Literature DB >> 7544112

Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1.

Y Yura1, J Kusaka, Y Kondo, H Tsujimoto, H Yoshida, M Sato.   

Abstract

Tyrphostins 9 and 47, inhibitors of protein-tyrosine kinase, inhibited the replication of herpes simplex virus type 1 (HSV-1), whereas tyrophostin 1, which does not inhibit protein-tyrosine kinase, did not affect the replication of HSV-1. The inhibitory effect of tyrphostin 9 was more potent than that of tyrphostin 47, and the IC50 of tyrphostin 9 was 40 nM. Sodium orthovanadate, an inhibitor of protein phosphotyrosine phosphatase, increased HSV-1 plaque formation and its effect was partly reversed by tyrphostin 9. The phosphorylation of viral phosphoproteins was decreased by tyrphostin 9 in a dose-dependent manner, but the tyrphostin 9-induced reduction of protein synthesis was not dose-dependent. At the late stage of infection, tyrosine phosphorylation was demonstrated in HSV-1 phosphoproteins. These results indicate that protein-tyrosine kinase is involved in the replication of HSV-1 and that tyrphostin can inhibit the synthesis and post-translational phosphorylation of the viral proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544112     DOI: 10.1007/bf01322745

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  38 in total

1.  Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1.

Authors:  D I Cohen; Y Tani; H Tian; E Boone; L E Samelson; H C Lane
Journal:  Science       Date:  1992-04-24       Impact factor: 47.728

2.  Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.

Authors:  Y Uehara; Y Murakami; Y Sugimoto; S Mizuno
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

3.  Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus.

Authors:  M Kurokawa; H Ochiai; K Nakajima; S Niwayama
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

4.  Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.

Authors:  J Markovits; C Linassier; P Fossé; J Couprie; J Pierre; A Jacquemin-Sablon; J M Saucier; J B Le Pecq; A K Larsen
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

5.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

6.  Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.

Authors:  A Gazit; P Yaish; C Gilon; A Levitzki
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

7.  An autophosphorylating but not transphosphorylating activity is associated with the unique N terminus of the herpes simplex virus type 1 ribonucleotide reductase large subunit.

Authors:  J Conner; J Cooper; J Furlong; J B Clements
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

9.  Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.

Authors:  A Esther; S Iftach; P Esther
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

10.  The interaction of ICP4 with cell/infected-cell factors and its state of phosphorylation modulate differential recognition of leader sequences in herpes simplex virus DNA.

Authors:  A G Papavassiliou; K W Wilcox; S J Silverstein
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more
  3 in total

1.  Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions.

Authors:  X Ren; J S Harms; G A Splitter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Role of the serine-threonine kinase PAK-1 in myxoma virus replication.

Authors:  J B Johnston; John W Barrett; Wen Chang; Che-Sheng Chung; Wei Zeng; Jennefer Masters; Melissa Mann; Fuan Wang; Jingxin Cao; Grant McFadden
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening.

Authors:  Sarah Straschewski; Martin Warmer; Giada Frascaroli; Heinrich Hohenberg; Thomas Mertens; Michael Winkler
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.